The blue social bookmark and publication sharing system.
Log in with your username.
I've lost my password.
Log in with your OpenID-Provider.
ImClone Systems and Bristol-Myers Squibb said yesterday that they would begin to provide their cancer drug, Erbitux, to a limited number of colorectal cancer patients who have exhausted other treatment options.